Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Genmab
AstraZeneca
Eli Lilly and Company
Lebanese University
M.D. Anderson Cancer Center
Gilead Sciences
Institut Curie